Hiskey Olivia, McKeirnan Kimberly, Frazier Cheyenne
Washington State University College of Pharmacy and Pharmaceutical Sciences, Department of Pharmacotherapy, Spokane, Washington.
Sr Care Pharm. 2023 May 1;38(5):193-207. doi: 10.4140/TCP.n.2023.193.
Telehealth practice in the ambulatory care pharmacy setting has seen extensive expansion because of the COVID-19 pandemic. Historically, evaluations of pharmacy-driven telehealth services have shown positive patient outcomes and high patient satisfaction, but little was known about pharmacist provider satisfaction. Additionally, barriers to telehealth practice have been highlighted with the widespread expansion of telehealth. With the push to continue high rates of telehealth use postpandemic, evaluation of current ambulatory care pharmacist telehealth practices is needed. This study aimed to evaluate ambulatory care pharmacists' perception of the telehealth services they provide, including barriers patients experience, solutions to address these barriers, and perceptions of the quality of care provided through telehealth. Ambulatory care pharmacists in Washington State were recruited to participate in a 16-item key informant interview. The Technology Acceptance Model was the theoretical framework applied to the interview questions and used to evaluate common themes emerging from the interviews. Common themes from the interviews included positive and negative attributes to telehealth care, pharmacist preferences for a video telehealth platform, technology access and use barriers for patients accessing telehealth, technology support from the provider's organization as an avenue to address these barriers, and patient-specific characteristics allowing high-quality health care through telehealth. Using these described common ideals, ambulatory care pharmacist telehealth best practices can be developed, including a personalized approach to this care. As we emerge from the COVID-19 pandemic, actively addressing common barriers as well as successfully identifying appropriate telehealth candidates will be essential in providing high-quality virtual care.
由于新冠疫情，门诊护理药房环境中的远程医疗实践得到了广泛扩展。从历史上看，对由药房推动的远程医疗服务的评估显示出积极的患者治疗效果和较高的患者满意度，但对于药剂师提供者的满意度了解甚少。此外，随着远程医疗的广泛扩展，远程医疗实践的障碍也凸显出来。随着疫情后继续保持高使用率的推动，需要对当前门诊护理药剂师的远程医疗实践进行评估。本研究旨在评估门诊护理药剂师对他们提供的远程医疗服务的看法，包括患者遇到的障碍、解决这些障碍的方法，以及对通过远程医疗提供的护理质量的看法。招募了华盛顿州的门诊护理药剂师参与一项包含16个项目的关键信息人访谈。技术接受模型是应用于访谈问题并用于评估访谈中出现的共同主题的理论框架。访谈中的共同主题包括远程医疗护理的积极和消极属性、药剂师对视频远程医疗平台的偏好、患者使用远程医疗的技术接入和使用障碍、提供者组织的技术支持作为解决这些障碍的途径，以及通过远程医疗实现高质量医疗护理的患者特定特征。利用这些描述的共同理念，可以制定门诊护理药剂师远程医疗的最佳实践，包括针对这种护理的个性化方法。随着我们从新冠疫情中走出，积极解决常见障碍以及成功识别合适的远程医疗候选人对于提供高质量的虚拟护理至关重要。
